These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20007957)

  • 1. Optimum use of diuretics in managing ascites in patients with cirrhosis.
    Bernardi M
    Gut; 2010 Jan; 59(1):10-1. PubMed ID: 20007957
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of intravenous mannitol in mobilization of resistant cirrhotic ascites.
    Raza MA; Qureshi UF; Humayoun MA; Waseem T; Akram J
    Eur J Gastroenterol Hepatol; 2011 Feb; 23(2):184-8. PubMed ID: 21183857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system.
    Lenaerts A; Codden T; Meunier JC; Henry JP; Ligny G
    Hepatology; 2006 Oct; 44(4):844-9. PubMed ID: 17006921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V2 receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatraemia--a randomized, double-blind, placebo-controlled study.
    Ginès P; Wong F; Watson H; Terg R; Bruha R; Zarski JP; Dudley F;
    Aliment Pharmacol Ther; 2010 Apr; 31(8):834-45. PubMed ID: 20102356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Renal insufficiency caused by diuretics in liver cirrhosis with ascites].
    Bosch J; Arroyo V; Rodes J; Teres J; Bordas JM; Bruguera M
    Rev Clin Esp; 1973 Dec; 131(5):375-82. PubMed ID: 4779095
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hazards of diuretics in treatment of ascitic cirrhosis].
    Reynaud R
    Maroc Med; 1969 Nov; 49(529):626-8. PubMed ID: 5371756
    [No Abstract]   [Full Text] [Related]  

  • 7. [Are metoclopramide and propranolol contraindicated, like nonsteroidal anti-inflammatory agents, in patients with cirrhosis and ascites?].
    Braillon A; Tribout B; Reix N; Capron JP
    Gastroenterol Clin Biol; 1986 Mar; 10(3):231-3. PubMed ID: 3732733
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preliminary clinical trials of ethacrynic acid in intravenous administration].
    Cicconetti C; Cantera N
    Minerva Med; 1970 Apr; 61(27):1363-7. PubMed ID: 5439718
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment with colchicine and survival of patients with ascitic cirrhosis: a double-blind randomized trial.
    Adhami JE; Basho J
    Panminerva Med; 1998 Mar; 40(1):75-81. PubMed ID: 9573762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].
    Cho HS; Park GT; Kim YH; Shim SG; Kim JB; Lee OY; Choi HS; Hahm JS; Lee MH
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):324-31. PubMed ID: 14695699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial.
    Angeli P; Fasolato S; Mazza E; Okolicsanyi L; Maresio G; Velo E; Galioto A; Salinas F; D'Aquino M; Sticca A; Gatta A
    Gut; 2010 Jan; 59(1):98-104. PubMed ID: 19570764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The combination of corticoids, spironolactone, salidiuretics and mannitol according to a particular schema of treatment of ascitic cirrhosis].
    Colucci CF
    Schweiz Med Wochenschr; 1966 May; 96(20):660-5. PubMed ID: 5988706
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bumetanide therapy of cirrhotic ascites. Comparison of different doses and modes of administration].
    Saffiotti O; Balzano A; Rinaldi M; Savarese M; Sito M; Del Vecchio-Blanco C
    Clin Ter; 1983 May; 105(4):281-8. PubMed ID: 6872470
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral V2 receptor antagonist (RWJ-351647) in patients with cirrhosis and ascites: a randomized, double-blind, placebo-controlled, single ascending dose study.
    Thuluvath PJ; Maheshwari A; Wong F; Yoo HW; Schrier RW; Parikh C; Steare S; Korula J
    Aliment Pharmacol Ther; 2006 Sep; 24(6):973-82. PubMed ID: 16948809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of ascites in liver cirrhosis].
    Geller LI
    Sov Med; 1991; (5):46-7. PubMed ID: 1876922
    [No Abstract]   [Full Text] [Related]  

  • 16. Amiloride (MK-870), a new antikaluretic diuretic. Comparison to other antikaluretic diuretics in patients with liver disease and ascites.
    Yamada S; Reynolds TB
    Gastroenterology; 1970 Dec; 59(6):833-41. PubMed ID: 5486268
    [No Abstract]   [Full Text] [Related]  

  • 17. [New "diuretics" in therapy of ascites].
    Schölmerich J; Andus T; Gross V; Leser HG; Gerok W
    Z Gastroenterol Verh; 1991 Mar; 26():144-8. PubMed ID: 1714129
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diuretic therapy in the course of hepatic cirrhosis with ascites].
    Del Prete S
    Osp Maggiore; 1965 Sep; 60(9):814-9. PubMed ID: 5850040
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical evaluation of the use of diuretics in the ascitic phase of hepatic cirrhosis].
    Castagnolo B; De Colibus V; Napolitano L; Aliperta A; Caldarelli G; Abignente F
    Clin Ter; 1977 Dec; 83(6):625-9. PubMed ID: 343976
    [No Abstract]   [Full Text] [Related]  

  • 20. [Combination therapy in diuretic resistance].
    Heinzl S
    Med Monatsschr Pharm; 1997 Apr; 20(4):85. PubMed ID: 9198723
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.